Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125550752 | 12555075 | 2 | F | 20160704 | 20160714 | 20160718 | EXP | DE-ROCHE-1791384 | ROCHE | 2.00 | YR | M | Y | 0.00000 | 20160718 | MD | DE | DE |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125550752 | 12555075 | 1 | PS | GANCICLOVIR. | GANCICLOVIR | 1 | Unknown | DOSE PER WEIGHT 55.56MG/KG AND TREATMENT PERIOD 91 DAYS. | U | 19661 | 500 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125550752 | 12555075 | 1 | Cytomegalovirus infection |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125550752 | 12555075 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125550752 | 12555075 | Agranulocytosis | |
125550752 | 12555075 | Infection | |
125550752 | 12555075 | Transplant rejection |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |